BRD4 in physiology and pathology: ‘‘BET’’ on its partners-Reference-Cited by-同舟云学术

BRD4 in physiology and pathology: ‘‘BET’’ on its partners

Published:2021-10-26 Issue:12 Volume:43 Page:2100180
ISSN:0265-9247
Container-title:BioEssays
language:en
Short-container-title:BioEssays

Author:

Liang Yin¹^ORCID,Tian Jieyi¹,Wu Tao¹^ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Carcinogenesis and Intervention School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University Nanjing People's Republic of China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bies.202100180

Reference135 articles.

1. Bromodomain biology and drug discovery

2. Beating the odds: BETs in disease

3. Cooperative binding of two acetylation marks on a histone tail by a single bromodomain

4. Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains

5. Targeting bromodomains: epigenetic readers of lysine acetylation

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel magnetic ligand-based assay for the electrochemical determination of BRD4;Talanta;2024-11

2. Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy;Bioorganic & Medicinal Chemistry;2024-10

3. Histone acetylation regulated by histone deacetylases during spermatogenesis;Andrology;2024-08-12

4. Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLC;Journal of Thoracic Oncology;2024-08

5. Interplay of condensation and chromatin binding underlies BRD4 targeting;Molecular Biology of the Cell;2024-06-01